Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-06-06
2006-06-06
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C514S255010
Reexamination Certificate
active
07056524
ABSTRACT:
A method of hydrating nasal airway surfaces in a subject in need of such treatment comprises topically applying a sodium channel blocker to a nasal airway surface of the subject in an amount effective to inhibit the reabsorption of water by the surface. The channel blocker may be a pyrazinoylguanidine sodium channel blocker, such as benzamil, phenamil, amiloride, or a pharmaceutically acceptable salts thereof. The method may further comprise the step of topically applying a P2Y2receptor agonist to a nasal airway surface of the subject in an amount effective to stimulate chloride secretion by the nasal airway surface. In a preferred embodiment, the sodium channel blocker is a covalent conjugate of a pyrazinoylguanidine sodium channel blocker and a non-absorbable carrier moiety (e.g., albumin, polyethylene glycol). Such compounds may also be administered to other mucosal surfaces where it is desired to inhibit the reabsorption of water.
REFERENCES:
patent: 3313813 (1967-04-01), Cragoe, Jr.
patent: 4294829 (1981-10-01), Suzuki et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4835142 (1989-05-01), Suzuki et al.
patent: 4894376 (1990-01-01), Morad et al.
patent: 5635160 (1997-06-01), Stutts, III et al.
patent: 5656256 (1997-08-01), Boucher et al.
patent: 5707644 (1998-01-01), Illum
patent: 5789391 (1998-08-01), Jacobus et al.
patent: 5876700 (1999-03-01), Boucher, Jr.
patent: 6264975 (2001-07-01), Boucher, Jr.
Knowles et al Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. The New England Journal of Medicine 325(8):533-538 (1991).
Thomas Taber's Cyclopedic Medical Dictionary F.A. Davis Company Philadelphia 1989.
Benos et al.,Purification and characterization of the amiloride-sensitive sodium channel from A6 cultured cells and bovine renal papilla, Proc. Natl. Acad. Sci. USA, 83:8525-8529 (1986).
Kleyman et al.,New amiloride analogue as hapten to raise anti-amiloride antibodies, Am. J. Physiol., 250 (Cell Physiol. 19):C165-C170 (1986).
Kleyman et al.,Amiloride and Its Analogs as Tools in the Study of Ion Transport, J. Membrane Biol., 105:1-21 (1988).
Knowles et al.,Activation By Extracellular Nucleotides of Chloride Secretion In The Airway Epithelia Of Patients With Cystic Fibrosis, The New England Journal of Medicine, 325(8):533-538 (1991).
Azpuru Carlos A.
The University of North Carolina at Chapel Hill
LandOfFree
Methods of hydrating mucosal surfaces does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of hydrating mucosal surfaces, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of hydrating mucosal surfaces will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701501